Ownership history in Birchview Capital, LP · 41 quarters on record
This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 67,200 | — | 0% | 1.37% | $2.3M | $34.80 |
| 2025 Q3 | UNCHANGED | 67,200 | — | 0% | 4.22% | $5.6M | $83.11 |
| 2025 Q2 | ADDED | 67,200 | +1,200 | +1.8% | 4.90% | $4.9M | $73.40 |
| 2025 Q1 | REDUCED | 66,000 | -8,000 | -10.8% | 6.55% | $7.5M | $114.22 |
| 2024 Q4 | UNCHANGED | 74,000 | — | 0% | 3.04% | $3.7M | $50.39 |
| 2024 Q3 | UNCHANGED | 74,000 | — | 0% | 2.97% | $3.4M | $46.28 |
| 2024 Q2 | ADDED | 74,000 | +24,000 | +48.0% | 2.23% | $2.4M | $32.49 |
| 2024 Q1 | UNCHANGED | 50,000 | — | 0% | 1.03% | $1.3M | $25.19 |
| 2023 Q4 | UNCHANGED | 50,000 | — | 0% | 1.27% | $1.6M | $32.48 |
| 2023 Q3 | UNCHANGED | 50,000 | — | 0% | 1.16% | $1.4M | $27.25 |
As of 2025 Q4 — sorted by position size